These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 29022506)

  • 21. Formyl Peptide Receptor 2 Is Involved in Cardiac Repair After Myocardial Infarction Through Mobilization of Circulating Angiogenic Cells.
    Heo SC; Kwon YW; Jang IH; Jeong GO; Lee TW; Yoon JW; Shin HJ; Jeong HC; Ahn Y; Ko TH; Lee SC; Han J; Kim JH
    Stem Cells; 2017 Mar; 35(3):654-665. PubMed ID: 27790799
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autologous bone marrow mononucleated cell preparation for the clinical treatment of acute myocardial infarction and peripheral arterial disease.
    Astori G; Bambi F; Soldati G; Sürder D; Moccetti T
    Cytotherapy; 2011 Oct; 13(9):1031-5. PubMed ID: 21916778
    [No Abstract]   [Full Text] [Related]  

  • 23. Efficacy and Safety of Autologous Cell-based Therapy in Patients with No-option Critical Limb Ischaemia: A Meta-Analysis.
    Wahid FSA; Ismail NA; Wan Jamaludin WF; Muhamad NA; Mohamad Idris MA; Lai NM
    Curr Stem Cell Res Ther; 2018; 13(4):265-283. PubMed ID: 29532760
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulating putative endothelial progenitor cells for the treatment of endothelial dysfunction and cardiovascular complications in diabetes.
    Wils J; Favre J; Bellien J
    Pharmacol Ther; 2017 Feb; 170():98-115. PubMed ID: 27773788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The therapeutic effect of autologous bone marrow cells in ischemic heart disease].
    Hristov M; Keymel S; Weber C
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():186-9. PubMed ID: 16802551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cell therapy for peripheral artery disease.
    Frangogiannis NG
    Curr Opin Pharmacol; 2018 Apr; 39():27-34. PubMed ID: 29452987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cell therapy for cardiovascular disease: what cells, what diseases and for whom?
    Caplice NM; Gersh BJ; Alegria JR
    Nat Clin Pract Cardiovasc Med; 2005 Jan; 2(1):37-43. PubMed ID: 16265341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial progenitor cells: regulation and contribution to adult neovascularization.
    Walter DH; Dimmeler S
    Herz; 2002 Nov; 27(7):579-88. PubMed ID: 12439630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Athena trials: Autologous adipose-derived regenerative cells for refractory chronic myocardial ischemia with left ventricular dysfunction.
    Henry TD; Pepine CJ; Lambert CR; Traverse JH; Schatz R; Costa M; Povsic TJ; David Anderson R; Willerson JT; Kesten S; Perin EC
    Catheter Cardiovasc Interv; 2017 Feb; 89(2):169-177. PubMed ID: 27148802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ANGPTL3 possibly promotes cardiac angiogenesis through improving proangiogenic ability of endothelial progenitor cells after myocardial infarction.
    Luo F; Wu P; Chen J; Guo Y; Wang J; Li X; Fang Z
    Lipids Health Dis; 2018 Aug; 17(1):184. PubMed ID: 30086775
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Transplantation of autologous skeletal myoblasts in ischemic cardiac insufficiency].
    Pouzet B; Hagège AA; Vilquin JT; Desnos M; Duboc D; Marolleau JP; Menashé P
    J Soc Biol; 2001; 195(1):47-9. PubMed ID: 11530499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical potential of adult vascular progenitor cells.
    Kumar AH; Caplice NM
    Arterioscler Thromb Vasc Biol; 2010 Jun; 30(6):1080-7. PubMed ID: 20453166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic angiogenesis of adipose-derived stem cells for ischemic diseases.
    Zhao L; Johnson T; Liu D
    Stem Cell Res Ther; 2017 Jun; 8(1):125. PubMed ID: 28583178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating endothelial progenitor cells: Do they live up to their name?
    Madonna R; De Caterina R
    Vascul Pharmacol; 2015; 67-69():2-5. PubMed ID: 25869520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pretreatment of endothelial progenitor cells with osteopontin enhances cell therapy for peripheral vascular disease.
    Vaughan EE; Liew A; Mashayekhi K; Dockery P; McDermott J; Kealy B; Flynn A; Duffy A; Coleman C; O'Regan A; Barry FP; O'Brien T
    Cell Transplant; 2012; 21(6):1095-107. PubMed ID: 22304991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
    Marsboom G; Janssens S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous Administration of Endothelial Colony-Forming Cells Overexpressing Integrin β1 Augments Angiogenesis in Ischemic Legs.
    Goto K; Takemura G; Takahashi T; Okada H; Kanamori H; Kawamura I; Watanabe T; Morishita K; Tsujimoto A; Miyazaki N; Ushikoshi H; Kawasaki M; Mikami A; Kosai K; Minatoguchi S
    Stem Cells Transl Med; 2016 Feb; 5(2):218-26. PubMed ID: 26702126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell therapy for heart failure: the need for a new therapeutic strategy.
    Povsic TJ; O'Connor CM
    Expert Rev Cardiovasc Ther; 2010 Aug; 8(8):1107-26. PubMed ID: 20670189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.
    Yerebakan C; Kaminski A; Westphal B; Liebold A; Steinhoff G
    Minim Invasive Ther Allied Technol; 2008; 17(2):143-8. PubMed ID: 18465448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous bone marrow-derived stem cells for ischemic heart failure: REGENERATE-IHD trial.
    Yeo C; Mathur A
    Regen Med; 2009 Jan; 4(1):119-27. PubMed ID: 19105621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.